| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. | Director | Stock Option (right to buy) | 30,000 | 16 Jul 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IKT | Inhibikase Therapeutics, Inc. | 16 Jul 2024 | 1 | $0 | 4 | Director | 18 Jul 2024, 17:27 |
| IKT | Inhibikase Therapeutics, Inc. | 30 Jun 2023 | 1 | $0 | 4 | Director | 05 Jul 2023, 21:12 |
| IKT | Inhibikase Therapeutics, Inc. | 24 Jun 2022 | 1 | $0 | 4 | Director | 28 Jun 2022, 21:00 |
| IKT | Inhibikase Therapeutics, Inc. | 25 Jun 2021 | 1 | $0 | 4 | Director | 29 Jun 2021, 19:11 |